Back to search

Article

Annual SZ® A Novel Formulation For COVID-19 Therapy Clinical Trial Studies

2025-06-05

Abstract excerpt

not-yet-known not-yet-known not-yet-known unknown The primary goal of this study is to identify an effective treatment for SARS-CoV-2. Our research was conducted in three phases: 1. Molecular Docking Analysis: We investigated the potential of artemisinin and its derivative to block viral entry by targeting the SARS-CoV-2 spike protein and RNA-dependent RNA polymerase (RDRP) using bioinformatics methods. 2. In...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d147fa89-c8e3-595c-8e4c-3497455ce3d7
DOI
10.22541/au.174910684.49737459/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Annual SZ® A Novel Formulation For COVID-19 Therapy Clinical Trial StudiesDOI 10.22541/au.174910684.49737459/v1
Discovery of Potential Inhibitors of the Receptor-binding Domain (RBD) of Pandemic Disease-causing SARS-CoV-2 Spike Glycoprotein from Triphala Through Molecular DockingSemantic proximity
Approaches to the Potential Therapy of COVID-19: A General Overview from the Medicinal Chemistry PerspectiveSemantic proximity
Druggable targets and therapeutic development for COVID-19Semantic proximity
The Pan-African Natural Products Library Compounds Oleanolic Acid, Poinsettifolin B, and Rhuschalcone III Disrupt SARS-CoV-2 Spike-Host ACE2 Interactions and SARS-CoV-2 ReplicationSemantic proximity
Artemisia argyi potentially prevents the infections with SARS-CoV-2 variantsSemantic proximity
Recent advances in small-molecular therapeutics for COVID-19Semantic proximity
In Silico Discovery and Evaluation of Inhibitors of the SARS-CoV-2 Spike Protein–HSPA8 Complex Towards Developing COVID-19 Therapeutic DrugsSemantic proximity
DEVELOPING NEW DUAL-ACTION ANTIVIRAL/ANTI-INFLAMMATORY SMALL MOLECULES FOR COVID-19 TREATMENT USING IN SILICO AND IN-VITRO APPROACHESSemantic proximity
In silico screening of known small molecules to bind ACE2 specific RBD on Spike glycoprotein of SARS-CoV-2 for repurposing against COVID-19Semantic proximity
Molecular Docking Reveals Ivermectin and Remdesivir as Potential Repurposed Drugs Against SARS-CoV-2Semantic proximity
TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351)Semantic proximity
There Was No New Needle in the COVID Therapeutic Haystack A COVID-19 Therapeutics AnalysisSemantic proximity
Select a neighboring publication to make it the new centre.